Paper Review Records
全部论文审稿周期
14 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
81
天
Critical roles of the long noncoding RNA SNHG4 in human cancers
作者
Yanpin Ma; Hairui Zhou展开收起
作者单位
1. Department of Oncology, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang, China; 2. Key Laboratory of Microecology-immune Regulatory Network and Related Diseases School of Basic Medicine, Jiamusi University, Jiamusi, China展开收起
149
天
NSUN2 regulates PARP9 progression through m5C modification to mediate breast cancer progression
作者
Xin Li; Changjiao Yan; Jun Yi; Jun Yun; Fengqiang Cui; Xiaolong Xu; Yike Li; Xin Xu展开收起
作者单位
1. Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, The Fourth Military Medical University, Xi’an, China展开收起
135
天
232
天
Transcription factor FOXA1 suppresses ferroptosis of cervical cancer cells by upregulating SLC7A11 expression
作者
Fei Gao; Yan Zeng; Li Jia; Jun He; Huarong He展开收起
作者单位
1. Department of Oncology, The Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang City, China; 2. Department of Radiology, The Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang City, China展开收起
216
天
p53 overexpression counteracts the pro-survival effect of Bcl-2 by restoring MAMs function in cutaneous squamous cell carcinoma
作者
Yupeng Huang; Jing Liu; Xiao Shao; Chunyan Xu; Xianpeng Ma展开收起
作者单位
1. Department of General Surgery, Affiliated Hospital of Beihua University, Jilin, China; 2. Department of Pharmacy, Affiliated Hospital of Beihua University, Jilin, China; 3. College of Biological and Pharmaceutical Engineering, Jilin Agricultural Science and Technology University, Jilin, China; 4. Department of Dermatology, Affiliated Hospital of Beihua University, Jilin, China展开收起
176
天
Esculentoside A suppresses the malignant progression of hepatocellular carcinoma by promoting RORB
作者
Qing Ye; Dousheng Bai; Aoqing Wang; Xi Zhang; Ruiqi Chai展开收起
作者单位
1. Department of Traditional Chinese Medicine, Subei People’s Hospital, Yangzhou, P. R. China; 2. Department of Traditional General Surgery, Subei People’s Hospital, Yangzhou, P. R. China; 3. Department of Proctology, Nanjing Hospital of Integrated Chinese and Western Medicine, Nanjing, P. R. China展开收起
FAQ
Cell Division审稿要多久?
截至2026-11-19,CrushSCI 收录了 Cell Division 的 14 篇完整审稿记录。最快一篇从收稿到录用用了 47 天(The TMPO-AS1/hsa-let-7b-5p regulatory axis shapes transcriptional heterogeneity and immune landscape in lung adenocarcinoma,2026-02-11 收稿,2026-03-30 录用),最慢一篇用了 235 天;平均 152.3 天,中位数 155 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
